The Impact of Medicare Part D on Hospitalization Rates
- 9 February 2011
- journal article
- Published by Wiley in Health Services Research
- Vol. 46 (4) , 1022-1038
- https://doi.org/10.1111/j.1475-6773.2011.01244.x
Abstract
To determine whether the change in prescription drug insurance coverage associated with Medicare Part D reduced hospitalization rates for conditions sensitive to drug adherence. Hospital discharge data from 2005 to 2007 for 23 states, linked with state-level data on drug coverage. We use a difference-in-difference-in-differences approach, comparing changes in the probability of hospitalization before and after the introduction of the Part D benefit in 2006, for individuals aged 65 and older (versus individuals aged 60-64) in states with low drug coverage in 2005 (versus those in states with high pre-Part D drug coverage). Hospitalization rates for selected ambulatory care sensitive conditions in 23 states were computed using data from the Census and Health Care Utilization Project. Drug coverage rates were computed using data from several sources. For the conditions studied, our point estimates suggest that Part D reduced the overall rate of hospitalization by 20.5 per 10,000 (4.1 percent), representing approximately 42,000 admissions, about half of the reduction in admissions over our study period. Conclusions. The increase in drug coverage associated with Medicare Part D had positive effects on the health of elderly Americans, which reduced use of nondrug health care resources.Keywords
This publication has 26 references indexed in Scilit:
- Falling into the Coverage Gap: Part D Drug Costs and Adherence for Medicare Advantage Prescription Drug Plan Beneficiaries with DiabetesHealth Services Research, 2010
- The Effect of Medicare Part D on Drug and Medical SpendingNew England Journal of Medicine, 2009
- Assessing the Impact of Drug Use on Hospital CostsHealth Services Research, 2009
- The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug BenefitsHealth Affairs, 2009
- How Much Should We Trust Differences-In-Differences Estimates?The Quarterly Journal of Economics, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Rates of avoidable hospitalization by insurance status in Massachusetts and MarylandPublished by American Medical Association (AMA) ,1992
- A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity resultsPublished by American Medical Association (AMA) ,1983
- A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for HeteroskedasticityEconometrica, 1980